Comerica Bank’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.17M | Buy |
4,600,000
+1,600,000
| +53% | +$1.45M | 0.02% | 758 |
|
|
2025
Q1 | $1.35M | Buy |
3,000,000
+2,200,000
| +275% | +$994K | 0.01% | 1328 |
|
|
2024
Q4 | $402K | Buy |
800,000
+550,000
| +220% | +$276K | ﹤0.01% | 1984 |
|
|
2024
Q3 | $226K | Hold |
250,000
| – | – | ﹤0.01% | 2246 |
|
|
2024
Q2 | $249K | Sell |
250,000
-295
| -0.1% | -$294 | ﹤0.01% | 2167 |
|
|
2024
Q1 | $370K | Buy |
250,295
+250,000
| +84,746% | +$370K | ﹤0.01% | 2029 |
|
|
2023
Q4 | $322 | Hold |
295
| – | – | ﹤0.01% | 3686 |
|
|
2023
Q3 | $348 | Buy |
+295
| New | +$348 | ﹤0.01% | 3738 |
|